Market Place
Sourcing Support
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
27 Jun 2024 //
FIERCE BIOTECH
Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Trial of CEL383
03 Aug 2023 //
BUSINESSWIRE
Celsius Therapeutics to Present Preclinical Data on Anti-TREM1 Antibody at ECCO
27 Feb 2023 //
BUSINESSWIRE
Celsius to Present Data on Anti-TREM1 Antibody for Inflammatory Bowel Disease
19 Jan 2023 //
BUSINESSWIRE
Applied BioMath Announces a Continuation of Collaboration with Celsius
04 Oct 2022 //
PRNEWSWIRE
Celsius Therapeutics Names Scientific Advisers
22 Sep 2022 //
BUSINESSWIRE
Celsius Therapeutics Appoints Sarah Grant, M.D., as Chief Medical Officer
25 Aug 2022 //
BUSINESSWIRE
Celsius turns up the heat with lead drug selection, $83M financing
25 Mar 2022 //
FIERCEBIOTECH
Servier, Celsius Therapeutics ink collaboration to identify and validate
22 Dec 2020 //
PHARMABIZ
Colorectal drug candidates focal point of new collaboration b/w Servier, Celsius
22 Dec 2020 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.